Neoadjuvant Therapy Among Patients Undergoing Resection for Non-Small-Cell Lung Cancer: A Single Institution Experience

被引：0
|
作者：
Gutierrez Sainz, L. [1 ]
Cruz, P. [1 ]
Villamayor, J. [1 ]
Martinez Recio, S. [1 ]
Esteban, I. [2 ]
Arias Lotto, F. [2 ]
Vinal, D. [1 ]
Sanchez Cabrero, D. [1 ]
Higuera, O. [1 ]
De Castro Carpeno, J. [1 ]
机构：
[1] La Paz Univ Hosp, Oncol Dept, Madrid, Spain
[2] La Paz Univ Hosp, Pathol Dept, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
non-small cell lung cancer; neoadjuvant therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.18-28
引用
收藏
页码：S1107 / S1108
页数：2
相关论文
共 50 条
  • [1] Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer
    Yendamuri, Sai
    Groman, Adrienne
    Miller, Austin
    Demmy, Todd
    Hennon, Mark
    Dexter, Elisabeth
    Picone, Anthony
    Nwogu, Chukwumere
    Dy, Grace K.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 53 (03) : 656 - 663
  • [2] Impact of neoadjuvant therapy on postoperative complications in non-small-cell lung cancer patients subjected to anatomic lung resection
    Sanchez, Alberto Cabanero
    Molina, Gemma Maria Munoz
    Fernandez, Sara Fra
    Garcia, Alfonso Muriel
    Ramos, Angel Cilleruelo
    Hernandez, Estor Martinez
    Trancho, Florentino Hernando
    Mata, Nicolas Moreno
    EJSO, 2022, 48 (09): : 1947 - 1953
  • [3] Revisiting neoadjuvant therapy in non-small-cell lung cancer
    Saw, Stephanie P. L.
    Ong, Boon-Hean
    Chua, Kevin L. M.
    Takano, Angela
    Tan, Daniel S. W.
    LANCET ONCOLOGY, 2021, 22 (11): : E501 - E516
  • [4] Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer
    Weiss, Glen J.
    Zeng, Chan
    Kelly, Karen
    Tran, Zung Vu
    Bunn, Paul A., Jr.
    CLINICAL LUNG CANCER, 2007, 8 (05) : 335 - 338
  • [5] Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience
    Rossi, Sabrina
    Finocchiaro, Giovanna
    Toschi, Luca
    Santoro, Armando
    IMMUNOTHERAPY, 2019, 11 (11) : 945 - 952
  • [6] Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer
    Boyce-Fappiano, David
    Nguyen, Quynh-Nhu
    Chapman, Bhavana, V
    Allen, Pamela K.
    Gjyshi, Olsi
    Pezzi, Todd A.
    De, Brian
    Gomez, Daniel
    Lin, Steven H.
    Chang, Joe Y.
    Liao, Zhongxing
    Lee, Percy
    Gandhi, Saumil J.
    CLINICAL LUNG CANCER, 2021, 22 (05) : E745 - E755
  • [7] NEOADJUVANT AND ADJUVANT THERAPY OF NON-SMALL-CELL LUNG-CANCER
    ROSE, LJ
    SEMINARS IN ONCOLOGY, 1991, 18 (06) : 536 - 542
  • [8] Neoadjuvant chemotherapy in non small cell lung cancer (NSCLC): A retrospective evaluation of a single institution experience
    Martin, C
    Oconors, J
    Coronado, C
    Toosen, G
    Van Kooten, M
    Chacon, M
    Rosemberg, C
    Chacon, R
    LUNG CANCER, 2005, 49 : S381 - S381
  • [9] POSTRECURRENT SURVIVAL OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER UNDERGOING A COMPLETE RESECTION
    ICHINOSE, Y
    YANO, T
    YOKOYAMA, H
    INOUE, T
    ASOH, H
    TAYAMA, K
    TAKANASHI, N
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 108 (01): : 158 - 161
  • [10] Carboplatin/Pemetrexed/Bevacizumab in the Treatment of Patients With Advanced Non-Small-Cell Lung Cancer: A Single-Institution Experience
    Malhotra, Binu
    Evans, Tracey
    Weiss, Jared
    Eaby, Beth
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Langer, Corey J.
    CLINICAL LUNG CANCER, 2010, 11 (03) : 192 - 197
12345